
Droqub-DM Tablet
Marketer
Cubic Lifesciences Private Limited
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Droqub-DM Tablet
Abdominal pain relief is provided by the combined medication, Relpax-DM Tablet. This medication effectively alleviates abdominal pain, distension, discomfort, and spasms by inducing relaxation in the stomach and intestinal muscles. Furthermore, it inhibits specific pain-inducing chemical signals. Relpax-DM Tablet should be taken with food, following your doctor's prescribed dosage and duration. Your individual dosage will depend on your health status and response to the treatment. Continue taking this medication for the duration advised by your physician; premature discontinuation may lead to symptom recurrence or condition exacerbation. Inform your healthcare provider of all other medications you are currently using, as interactions are possible. Common side effects include diarrhea, nausea, vomiting, stomach ache, dry mouth, appetite loss, thirst, and heartburn; these are usually transient and self-limiting. Report any concerning side effects to your doctor immediately. Dizziness and drowsiness are potential effects; refrain from driving or activities demanding concentration until you assess your response. Alcohol consumption should be avoided due to potential dizziness exacerbation. Before commencing treatment, inform your doctor if you are pregnant, considering pregnancy, or breastfeeding. Similarly, disclose any existing kidney or liver conditions to allow for appropriate dosage adjustment.
Primary Ingredients of Droqub-DM Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Droqub-DM Tablet
Managing abdominal discomfort
Major Benefits of Droqub-DM Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Droqub-DM Tablet with a meal.
Common Side effects of Droqub-DM Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Droqub-DM Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the Droqub-DM Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with food.
How Droqub-DM Tablet works:
Droqub-DM tablets combine drotaverine and mefenamic acid to alleviate abdominal pain and cramping. Drotaverine, an antispasmodic, targets abdominal smooth muscle spasms by reducing contractions. Mefenamic acid, a nonsteroidal anti-inflammatory drug (NSAID), diminishes abdominal pain and inflammation by inhibiting the production of pain-inducing and swelling-causing chemicals.
SAFETY ADVICE
AlcoholUNSAFE
Combining Droqub-DM Tablet and alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Droqub-DM Tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks before prescribing this medication. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Lactation-related data for Droqub-DM Tablet is currently unavailable. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by Droqub-DM Tablet, as it can induce dizziness.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Droqub-DM tablets, potentially requiring dosage modification under medical supervision. Droqub-DM tablets are contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should exercise caution when using Droqub-DM Tablets. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Droqub-DM Tablet :
Should you forget a Droqub-DM Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Droqub-DM Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
